Sean M O'Hare

Title: Sean M O'Hare: Innovator in Peptide and Thiomolybdate Research

Introduction

Sean M O'Hare is a notable inventor based in San Diego, CA, who has made significant contributions to the fields of peptide and thiomolybdate research. With a total of 2 patents, his work focuses on developing innovative solutions for diseases associated with aberrant vascularization and other health disorders.

Latest Patents

O'Hare's latest patents include groundbreaking inventions that address critical health issues. The first patent involves peptides that inhibit angiogenesis, cell migration, cell invasion, and cell proliferation. This invention encompasses methods for creating these peptides, pharmaceutical compositions, and their applications in treating diseases linked to abnormal vascularization. The second patent introduces novel thiomolybdate derivatives, detailing methods for their synthesis, pharmaceutical compositions, and their potential use in treating various disorders, including copper metabolism disorders, neurodegenerative diseases, obesity, and NF-κB dysregulation.

Career Highlights

Throughout his career, Sean M O'Hare has worked with reputable organizations, including Attenuon, LLC and the University of Michigan. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research endeavors.

Collaborations

Some of O'Hare's notable coworkers include Robert J Ternansky and Andrew P Mazar, who have contributed to his research projects and innovations.

Conclusion

Sean M O'Hare's contributions to peptide and thiomolybdate research highlight his commitment to advancing medical science. His innovative patents and collaborations with esteemed organizations and individuals underscore his role as a significant inventor in the field.